Compare Blackstone Inc (BX) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Blackstone Inc vs Novavax Inc — how do they compare? Blackstone Inc trades at $147.55 (market cap $117.44B), while Novavax Inc trades at $7.97 (market cap $1.31B). The key difference: Blackstone Inc is far larger — about 89.6× Novavax Inc's market cap, and Blackstone Inc pays a 3.55% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| BX | NVAX | |
|---|---|---|
Market Cap | $117.44B | $1.31B |
Sector | Financials | Health |
52-Week High | $188.68 | $11.19 |
52-Week Low | $102.12 | $6.22 |
Dividend Yield | 3.55% | — |
Enterprise Value | — | $889.30M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Blackstone Inc
Blackstone is one of the world's largest alternative asset managers with $940.8 billion in total asset under management, including $683.8 billion in fee-earning asset under management, at the end of June 2022.
Read more on BX →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
